You get it all with your ticket to Terpenes and Testing World Conference.

All-Access Ticket: This ticket provides you all the benefits of Social Media Marketing World, including access to ALL of our content (including creator tracks), workshops, parties and session recordings.

PANEL – “The Future of Supercritical Extraction”With a methodology quickly evolving into an industry standard, what does the future hold for supercritical extraction techniques? The expert panelists will provide a general summary of supercritical extractions, including the benefits and limitations of this technique. Supercritical extraction will be contrasted with other extraction techniques, as in those performed with other solvents such as butane and propane and fluorocarbons. An economic analysis will be presented depicting the equipment costs and average cost per extraction, also compared with other techniques.

PANEL – “Biopesticides in Cannabis Cultivation”There’s been ample conversation regarding cannabis flower and concentrate samples exhibiting contamination from pesticide concentrations above set exposure thresholds, or the cultivation of Cannabis using pesticides known to be health hazards. Just the word “pesticide” seems to have created a public safety quagmire. Our panelists will discuss an alternative option to using toxic chemicals to rid your cultivation from unwanted pests. Could ladybugs, praying mantises, or different types of fungi and bacteria really be the answer? The discussion will introduce types of bio-pesticides that might be employed in a grow-house. The audience will also be presented with a cost and efficacy analysis of using this eco-friendly strategy versus traditional pesticides, as well as potential reductions in carbon footprints by switching to this greener substitute.

PANEL – “Software, Tech and Cannabis Science”We live in a technologically savvy society. There are software apps and gadgets for everything. The cannabis industry has presented the prospect for lots of different businesses to develop novel technologies, such as smartphone apps like Leafly and Weed Maps, or software platforms to keep track of vast sums of data like Headset and LIMS, to technologies geared towards producing healthier, happier plants, just to name a few. Others have generated organizations to journey on knowledge quests, such that a larger body of research exists for patients and the doctors who may guide them to have a better understanding of what cannabis products work best for them. This panel will highlight several of these technologies, and how they can advance our understanding of cannabis.

Matthew SimonScience Writer
WIRED MagazineModerator

12:30 p.m. – 1:00 p.m.

PRESENTATION – “Sample Prep Logistics”

Lane YagoPresident
Obiotics

1:15 p.m. – 1:45 p.m.

PRESENTATION – “Testing Lab Proficiency”

Wes BurkVice President
Emerald Scientific

2:00 p.m. – 2:30 p.m.

PRESENTATION – “Navigating the Challenges of Cannabis Sampling and Analysis”

PANEL – “Investing in Cannabis”The abundance of different products that contain cannabis-derived active product ingredients (APIs), such as CBD and THC, have extended to non-ingestible products like topical creams and salves, or patches that distribute the cannabinoid(s) through the skin. Cannabis offers antimicrobial, anti-inflammatory, and anti-itching properties. For example, the medical attributes of cannabis or hemp for treating skin conditions like eczema have been documented. Patients who don’t want to smoke or ingest APIs can turn to medicinal patches. Additionally, while some terpenes can cause skin irritation, limonene is thought to assist other medicinal terpenes in absorbing through the skin. What works best for specific conditions? Are there specific cannabinoids or cannabinoid/terpene profiles one should seek out? Should patients dose much the same as when putting something into their body? Our panelists will address many of these topics, including any advice they have for patients seeking this type of product.

PANEL – “Investing in Cannabis”A quick survey of the tax dollars generated by states having legalized cannabis recreationally will convey the sums of money being made by cannabis businesses. While, of course, some of the profits go back to the state in the form of licensing fees, the sheer volumes of sales mean someone somewhere is making money. While lots of folks are keen to invest their money in cannabis businesses, how exactly does one go about doing that when the industry is not federally regulated? This panel will provide instruction and advice to the audience on how they too can capitalize from the profits generated by legalized cannabis from discussing the types of opportunities available, to a risk assessment, and potential returns on investment.

PANEL – “The Future of Hydrocarbon Extraction”Is there a place at the table for all the solvent extractions? Our expert panelists will educate with a general summary of the all the possible solvents that can and are used, to the benefits and limitations of this technique. The discussion will also cover ways to mitigate solvent contamination in the final, consumer product. Contrasting one extraction from another with other extraction techniques, such as supercritical CO2 or other solvent-less methodologies. An economic analysis will be presented illustrating the equipment costs and average cost per extraction, also compared with other techniques.

PRESENTATION – “Putting Regulations to the Test: A Comparative Analysis of State Testing Standards”

Rebecca GascaFounder and CEO
Pistil and Stigma

3:30 p.m. – 4:15 p.m.

PANEL – “In-House Analyzers”In-house testing is used in many industries, including food and pharma, for quality control of incoming raw materials, optimizing and monitoring manufacturing processes, and testing of final products to make sure what is made is consistent, safe, and effective. Any manufacturer needs to actively implement some type of quality control protocol to ensure that the products generated are consistently within defined specifications. Cannabis cultivators and manufacturers must submit a representative sample to a lab to generate data regarding the chemical profile and safety of the products, however, in-house evaluations of products can assist businesses in making more educated decisions. To date, the cannabis industry does not perform enough in-house testing. There exist several instruments that allow cannabis businesses to perform potency testing; however, not all of these instruments use proven technology, and end users must do their homework to make sure they get an instrument that actually and accurately works and meets their needs. It is paramount to ask vendors for data to back up their claims. The members of this panel will discuss these options, as well as how in-house analyzers compare to standard lab instrumentation such as chromatography. The dialogue will include topics like analyzer accuracy, how a user knows that the instrument is properly calibrated if the device cannot measure commercial cannabinoid standards, a cost-comparison with other cutting-edge methods to analyze products, and how the lack of analytical standardization has affected data comparison.

Talked About

We Transfer

PayPal me

Join Us

The Terpenes and Testing Bi-Monthly print magazine is a complete technical reference. This blog is separate from the magazine as it addresses the latest cannabis news, product reviews, and more colloquial subject matter. Please refer to our editorial content for a comprehensive assessment of these complicated practices.
----

Copyright ®2017 - Terpenes and Testing Magazine - All rights reserved. Created and powered by The Cannabis Marketing Lab